Profile | GDS4284 / 243430_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 427.643 | 62 |
GSM687648 | Patient 402 control | 277.357 | 55 |
GSM687653 | Patient 403 control | 362.508 | 60 |
GSM687658 | Patient 404 control | 315.054 | 56 |
GSM687663 | Patient 411 control | 417.66 | 60 |
GSM687668 | Patient 422 control | 261.985 | 54 |
GSM687673 | Patient 424 control | 339.696 | 57 |
GSM687678 | Patient 425 control | 108.393 | 35 |
GSM687683 | Patient 427 control | 450.082 | 61 |
GSM687688 | Patient 428 control | 201.64 | 49 |
GSM687695 | Patient 441 control | 969.11 | 75 |
GSM687699 | Patient 443 control | 411.711 | 59 |
GSM687704 | Patient 444 control | 238.925 | 52 |
GSM687707 | Patient 448 control | 362.055 | 57 |
GSM687712 | Patient 449 control | 386.436 | 59 |
GSM687719 | Patient 450 control | 473.398 | 61 |
GSM687724 | Patient 451 control | 85.8816 | 29 |
GSM687728 | Patient 452 control | 285.872 | 54 |
GSM687646 | Patient 401 treated 24h | 329.037 | 56 |
GSM687649 | Patient 402 treated 24h | 101.67 | 37 |
GSM687665 | Patient 411 treated 24h | 554.138 | 65 |
GSM687651 | Patient 402 treated 4 weeks | 335.619 | 57 |
GSM687667 | Patient 411 treated 4 weeks | 262.928 | 53 |
GSM687670 | Patient 422 treated 24h | 326.043 | 56 |
GSM687671 | Patient 422 treated 4 weeks | 293.933 | 55 |
GSM687654 | Patient 403 treated 24h | 344.101 | 59 |
GSM687675 | Patient 424 treated 24h | 584.844 | 65 |
GSM687685 | Patient 427 treated 24h | 363.08 | 58 |
GSM687656 | Patient 403 treated 4 weeks | 357.849 | 59 |
GSM687677 | Patient 424 treated 4 weeks | 313.682 | 56 |
GSM687687 | Patient 427 treated 4 weeks | 164.645 | 46 |
GSM687692 | Patient 428 treated 4h | 265.565 | 53 |
GSM687716 | Patient 449 treated 4h | 175.594 | 47 |
GSM687722 | Patient 450 treated 4h | 564.835 | 65 |
GSM687680 | Patient 425 treated 24h | 241.582 | 52 |
GSM687690 | Patient 428 treated 24h | 423.594 | 62 |
GSM687700 | Patient 443 treated 24h | 838.159 | 70 |
GSM687705 | Patient 444 treated 24h | 234.044 | 53 |
GSM687714 | Patient 449 treated 24h | 322.584 | 58 |
GSM687721 | Patient 450 treated 24h | 568.238 | 64 |
GSM687682 | Patient 425 treated 4 weeks | 358.334 | 59 |
GSM687694 | Patient 428 treated 4 weeks | 258.532 | 54 |
GSM687702 | Patient 443 treated 4 weeks | 481.864 | 62 |
GSM687718 | Patient 449 treated 4 weeks | 431.742 | 62 |
GSM687723 | Patient 450 treated 4 weeks | 295.962 | 55 |
GSM687661 | Patient 404 treated 4h | 518.225 | 64 |
GSM687710 | Patient 448 treated 4h | 122.903 | 38 |
GSM687726 | Patient 451 treated 4h | 474.829 | 62 |
GSM687730 | Patient 452 treated 4h | 1726.75 | 83 |
GSM687660 | Patient 404 treated 24h | 606.753 | 68 |
GSM687697 | Patient 441 treated 24h | 899.066 | 73 |
GSM687709 | Patient 448 treated 24h | 310.161 | 56 |
GSM687725 | Patient 451 treated 24h | 293.743 | 53 |
GSM687729 | Patient 452 treated 24h | 677.022 | 69 |
GSM687727 | Patient 451 treated 4 weeks | 256.067 | 51 |
GSM687731 | Patient 452 treated 4 weeks | 322.705 | 55 |